Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania School of Medicine, 764 CRB, 415 Curie Blvd., Philadelphia, PA 19104, USA.
Osteoporos Int. 2011 Jan;22(1):339-44. doi: 10.1007/s00198-010-1187-4. Epub 2010 Mar 4.
Hormone levels were compared over a 1-year period between elderly women who had sustained a hip fracture and women of similar age and functional ability. Our study suggests progressive hormonal changes that may contribute to severe bone loss during the year following hip fracture.
Alterations in hormones affecting the musculoskeletal system may increase risk of hip fracture or poor post-fracture recovery in postmenopausal women. Most studies lack appropriate reference groups, and thus cannot assess the extent to which these alterations are attributable to hip fracture.
Women aged ≥65 years hospitalized for an acute hip fracture (Baltimore Hip Studies, BHS-3; n = 162) were age-matched to 324 women enrolled in the Women's Health and Aging Study I, a Baltimore-based cohort with similar functional status to the pre-fracture status of BHS-3 women. Both studies enrolled participants from 1992 to 1995. Insulin-like growth hormone-1 (IGF-1), parathyroid hormone (PTH), 1,25 dihydroxyvitamin D [1,25(OH)2D], and osteocalcin were evaluated at baseline and 2, 6, and 12 months post-fracture, and at baseline and 12 months in the comparison group. Between-group differences in trajectories of each hormone were examined.
Baseline mean IGF-1 levels were significantly lower in hip fracture patients than the comparison group (75.0 vs. 110.5 μg/dL; p < 0.001). Levels increased by 2 months post-fracture, but remained significantly lower than those in the comparison group throughout the 12-month follow-up (p < 0.01). Levels of PTH and osteocalcin were similar between groups at baseline, but rose during the year post-fracture to significantly differ from the comparison women (p < 0.001). 1,25(OH)2D levels did not differ between the hip fracture and comparison women at any time.
Older women who have sustained a hip fracture have progressive changes in hormonal milieu that exceed those of women of similar health status during the year following fracture.
比较髋部骨折的老年女性与年龄和功能能力相似的女性在 1 年内的激素水平。我们的研究表明,激素的渐进性变化可能导致髋部骨折后 1 年内严重的骨质流失。
影响骨骼肌肉系统的激素改变可能会增加绝经后妇女髋部骨折或骨折后恢复不良的风险。大多数研究缺乏适当的参考群体,因此无法评估这些改变在多大程度上归因于髋部骨折。
对因急性髋部骨折(巴尔的摩髋部研究,BHS-3;n=162)住院的年龄≥65 岁的女性进行年龄匹配,纳入 1992 年至 1995 年参加巴尔的摩妇女健康与衰老研究 I 的 324 名女性。这两项研究都招募了功能状态与 BHS-3 女性骨折前状态相似的参与者。在骨折后 2、6 和 12 个月及对照组的基线和 12 个月时,评估胰岛素样生长因子 1(IGF-1)、甲状旁腺激素(PTH)、1,25 二羟维生素 D [1,25(OH)2D]和骨钙素。检查了每组激素轨迹的组间差异。
与对照组相比,髋部骨折患者的基线平均 IGF-1 水平显著较低(75.0 与 110.5μg/dL;p<0.001)。骨折后 2 个月时水平升高,但在整个 12 个月的随访中仍显著低于对照组(p<0.01)。两组基线时 PTH 和骨钙素水平相似,但在骨折后 1 年内升高,与对照组女性明显不同(p<0.001)。1,25(OH)2D 水平在任何时候均无髋部骨折组与对照组之间的差异。
髋部骨折的老年女性在骨折后 1 年内的激素环境发生了渐进性变化,超过了骨折后健康状况相似的女性。